Generalized vitiligo after lymphocyte infusion for relapsed leukaemia

British Journal of Dermatology

Volumn 145, Issue 6, 2001, Pages 1015-1017

  Au, W Y ^a   Yeung, C K ^a   Chan, H H ^a   Lie, A K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bone marrow transplantation; Donor lymphocyte infusion; Leucotrichia; Leukaemia; Melanocytes; Vitiligo

Indexed keywords

ADULT; ALLOIMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CASE REPORT; CELL DESTRUCTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LYMPHOCYTE TRANSFUSION; LYMPHOPOIESIS; MALE; MELANOCYTE; PRIORITY JOURNAL; RECIPIENT; RELAPSE; VITILIGO;

ADULT; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE TRANSFUSION; MALE; RECURRENCE; VITILIGO;

EID: 0035726447     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04500.x     Document Type: Article

References (19)

1. Pathophysiology of vitiligo
2. Vitiligo: Clinical findings in 1436 patients
3. Management of vitiligo. Results of a questionnaire among dermatologists in the Netherlands
4. Total leucoderma: A rare manifestation of cutaneous chronic graft-versus-host disease
5. Graft-versus-host reactions in dermatology
6. Incidence of graft-versus-host disease in Hong Kong Chinese and its influence on survival after bone marrow transplantation from HLA-identical siblings
7. Essential thrombocythemia with BCR/ABL rearrangement
8. Extramedullary relapse of acute lymphoblastic leukemia after allogeneic bone marrow transplantation
9. Therapy related myelodysplastic syndrome of recipient origin after allogeneic bone marrow transplantation for acute lymphoblastic leukaemia
10. Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo
11. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site
12. Lymphocyte populations in dermal lymphoid aggregates of vitiliginous Smyth line and normally pigmented light brown Leghorn chickens
13. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance
14. Regional administration of lymphokine-activated killer cells can be superior to intravenous application
15. Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma
16. Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase
17. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: A pilot study
18. Genetic immunization of mice with human tyrosinase-related protein 2: Implications for the immunotherapy of melanoma
19. Epidermal grafts for treatment of stable and progressive vitiligo